Blincyto Avrupa Birliği - Hırvatça - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - prekursorska stanica limfoblastične leukemije-limfom - antineoplastična sredstva - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Cortef 10 mg tablete Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

cortef 10 mg tablete

pfizer croatia d.o.o., slavonska avenija 6, zagreb, hrvatska - hidrokortizon - tableta - 10 mg - urbroj: jedna tableta sadrži 10 mg hidrokortizona

Orylmyte 100 IR i 300 IR sublingvalne tablete Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

orylmyte 100 ir i 300 ir sublingvalne tablete

stallergenes, 6 rue alexis de tocqueville, antony, francuska - standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides pteronyssinus standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides farinae - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 100 ir ili 300 ir standardiziranog alergenog ekstrakta grinja kućne prašine dermatophagoides pteronyssinus i dermatophagoides farinae u jednakim dijelovima

Orylmyte 100 IR sublingvalne tablete Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

orylmyte 100 ir sublingvalne tablete

stallergenes, 6 rue alexis de tocqueville, antony, francuska - standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides pteronyssinus standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides farinae - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 100 ir standardiziranog alergenog ekstrakta grinja kućne prašine dermatophagoides pteronyssinus i dermatophagoides farinae

Orylmyte 300 IR sublingvalne tablete Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

orylmyte 300 ir sublingvalne tablete

stallergenes, 6 rue alexis de tocqueville, antony, francuska - standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides pteronyssinus standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides farinae - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 300 ir standardiziranog alergenog ekstrakta grinja kućne prašine dermatophagoides pteronyssinus i dermatophagoides farinae

Breyanzi Avrupa Birliği - Hırvatça - EMA (European Medicines Agency)

breyanzi

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastična sredstva - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Zesuva 12,5 mg tvrde kapsule Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

zesuva 12,5 mg tvrde kapsule

zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - сунитиниб - kapsula, tvrda - 12,5 mg - urbroj: jedna kapsula sadrži 12,5 mg sunitiniba

Zesuva 25 mg tvrde kapsule Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

zesuva 25 mg tvrde kapsule

zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - сунитиниб - kapsula, tvrda - 25 mg - urbroj: jedna kapsula sadrži 25 mg sunitiniba

Zesuva 50 mg tvrde kapsule Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

zesuva 50 mg tvrde kapsule

zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - сунитиниб - kapsula, tvrda - 50 mg - urbroj: jedna kapsula sadrži 50 mg sunitiniba

Dexeto 4 mg/ml otopina za injekciju/infuziju Hırvatistan - Hırvatça - HALMED (Agencija za lijekove i medicinske proizvode)

dexeto 4 mg/ml otopina za injekciju/infuziju

krka d.d., novo mesto, Šmarješka cesta 6, novo mesto, slovenija - natrijev deksametazonfosfat - otopina za injekciju / infuziju - 4 mg/ml - urbroj: jedna ampula od 1 ml sadrži 4 mg deksametazonfosfata (u obliku natrijevog deksametazonfosfata)